WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody
Clinical trial NCT06106152 · UNKNOWN
Trial details
- NCT number
- NCT06106152
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-05
- Primary completion
- 2024-10-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.